Abstract
The metabolic syndrome is now regarded as a contributor to coronary heart disease (CHD), and components of the syndrome have thought to be potential therapeutic targets. Previous study indicates neurotransmitter activation related to psychosocial stress as a key factor to the metabolic syndrome. The
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
